Skip to content

Effect of Superfresh Whitening Toothpaste for Breath Freshness and Whitening Effect in Healthy adults

Evaluation of SuperFresh Whitening Toothpaste for Breath Freshness Efficacy and Whitening Effect in a Single-Arm Clinical Study. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090959
Enrollment
30
Registered
2025-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K088- Other specified disorders of teethand supporting structures

Interventions

Intervention1: SuperFresh Whitening Toothpaste: Sorbitol, Hydrated Silica, Aqua, Glycerine, Probiotics, Xylitol, Erythritol, Xanthan Gum, Nano-Hydroxyapatite, Vitamin E, ImerCare PerlWhite 19, Sodium

Sponsors

Chipper Consumer Pvt Ltd Perfora
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Healthy adult Participants in the age group of 18-60 years who prefer to improve teeth shade cosmetically and who would want to maintain oral hygiene and to comply with the study procedures. study procedures. Tooth shades: B2, D2, A2, C2, D3, A3, D4, B3, A3.5, B4, C3, A4, and C4. Gingivitis Severity: Participants must have a L e and Silness Gingival Index score greater than 1, indicating moderate to severe gingival inflammation. Dental Plaque Level: Participants must have a Turesky modification of the Quigley-Hein Plaque Index score greater than 1. Good general health with no systemic conditions affecting oral health. Presence of natural teeth with visible extrinsic stains or discoloration. Willingness to avoid other whitening treatments during the study period. Ability to provide informed consent. Compliance with study protocols, including scheduled visits and post-treatment care.

Exclusion criteria

Exclusion criteria: Tooth shades: A1, B1 and C1 Wearing orthodontic appliances like a clear aligner, retainer, and night guard/ braces. Participants with mal-aligned teeth and removable partial dentures Participants with chronic or aggressive periodontitis; who underwent recent whitening intervention Tobacco consumers, smokers and betel chewers. Participants who are pregnant or lactating. Participants with hypersensitivity to any of the test products. Participants with pre-existing tooth sensitivity Concurrent use of any other treatment for teeth whitening or sensitivity Concurrent participation in any other clinical trial or study involving teeth whitening or sensitivity assessment. Severe enamel defects or intrinsic discoloration unrelated to staining. Prior participation in a similar study within the past six months. Current use of medications causing tooth discoloration, such as tetracycline

Design outcomes

Primary

MeasureTime frame
To assess improvement in VITA shade (by using VITA Easy Shade Evaluate the efficacy of the product in preventing mouth odour, providing a sustained sensation of oral freshness for up to 12 hours, and maintaining fresh breath throughout the day, as well as promoting a clean and healthy oral environment . The assessment will be conducted by using Organoleptic Scoring Scale (OSS) and Assessment by Halimeter. 5- 3D master) scale over various time points. [Time Frame: Baseline, Day 30 and Day 60] Macpherson Stain Index Oral Hygiene Index Simplified (OHI-S) Dental Plaque will be assessed using Turesky modification of the Quigley Hein Plaque Index. Baseline, Day 30 and Day 60] Gingivitis scale using Loe and Silness Gingival Index. [Time Frame: Baseline, Day 30 and Day 60] Photographic assessment of oral cavity [Baseline & Day 60]Timepoint: Baseline, Day 30 and Day 60

Secondary

MeasureTime frame
Participants will be provided with a diary to monitor usage Page 9 of 45 Protocol No: SFW/07/25 Version: 1.1 OUTCOME Participant and Investigator feedback will be obtained using 5-point likert scale questionnaire Adverse event monitoringTimepoint: Baseline, Day 30 and Day 60

Countries

India

Contacts

Public ContactDr Gayathri Sivakumar

Ki3 Private Limited

saheerose@gmail.com09443627722

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026